Pre-operative Bowel Preparation Prior to Minimally Invasive Sacral Colpopexy
Study Details
Study Description
Brief Summary
Prior to surgery, gynecologists and urogynecologists have routinely prescribed preoperative mechanical bowel preparations in attempts to decrease the risk of infection, while also providing easier bowel manipulation and better visualization during surgery. However, many of these proposed benefits have never been proven, and usage of bowel preparations amongst surgeons remains highly variable. In both the general surgery and gynecology literature, researchers have begun to question the need for the vigorous preparations.
Aside from surgical visualization, urogynecologists have additional concerns about how bowel preparations may impact postoperative bowel function given up to half of women with pelvic floor disorders have baseline constipation and straining is known to impact surgical recovery. Many studies have addressed various postoperative fiber and laxative preparations in attempts to improve postoperative bowel-related symptomatology, but none have specifically looked at preoperative bowel preparations.
This study aims to determine if mechanical bowel preparation prior to minimally invasive sacral colpopexy affects patients' postoperative recovery, specifically related to bowel symptomatology; operative or post-operative complications; surgeons' perceptions of surgical difficulty directly attributed to the bowel; and post-operative return of normal bowel function.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Bowel Preparation Women randomized to the bowel preparation arm will be instructed to consume 300cc of magnesium citrate no later than 3PM on preoperative day number one. They will also be placed on a clear liquid diet on preoperative day number one. |
Other: Bowel preparation
Subjects randomized to the mechanical bowel preparation arm will be instructed to consume 300cc of magnesium citrate no later than 3PM on preoperative day number one.
Other Names:
|
Other: No bowel preparation Subjects randomized to no bowel preparation will be instructed to continue a regular diet on preoperative day number one. |
Other: No bowel preparation
Subjects randomized to no bowel preparation will be instructed to continue a regular diet on preoperative day number one.
|
Outcome Measures
Primary Outcome Measures
- PAC-SYM [1 year]
Bowel symptomatology and bowel-related discomfort will be assessed with the Patient Assessment of Constipation Symptom Questionnaire (PAC-SYM), a 12-item questionnaire covering three domains: abdominal, rectal, and stool.
Secondary Outcome Measures
- Surgeon perception of bowel preparation [1 year]
Immediately after completing the surgical case, surgeons will complete a 13-item surgeon questionnaire assessing degree of surgical difficulty and how it relates to the bowel. Operative time and consultations will also be recorded as objective measures of surgical difficulty.
- Return of normal bowel function [1 year]
A seven-day bowel diary will be obtained at baseline and in the first week after surgery. This log will include daily assessment of bowel frequency, type of bowel movement using the validated Bristol stool scale, degree of straining, and used of narcotics or laxatives.
- Perioperative complications [1 year]
Complications occurring in both groups will be recorded. These include, but are not limited to infections, bowel obstructions, visceral organ injuries, and readmissions.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Female
-
Age ≥ 18 years
-
Planned laparoscopic or robotic-assisted sacral colpopexy
Exclusion Criteria:
-
History of ulcerative colitis or Crohn's disease
-
Prior large or small bowel resection
-
Known diagnosis of gastroparesis
-
Prior pelvic radiation
-
History of abdominal or pelvic malignancy
-
Planned concurrent bowel surgery/anal sphincteroplasty/ rectovaginal fistula repair
-
Pregnancy
-
Known allergic reactions to components of the study products
-
Known renal insufficiency
-
Non-English speaking as the primary study questionnaires are all currently in English only
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | United States | 15213 |
Sponsors and Collaborators
- Halina M Zyczynski, MD
Investigators
- Principal Investigator: Kelly L Kantartzis, MD, University of Pittsburgh
- Principal Investigator: Halina M Zyczynski, MD, University of Pittsburgh
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PRO12020453